• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Association Between Functional Impairment and Medication Burden in Adults with Heart Failure.心力衰竭成年人的功能障碍与药物负担之间的关系。
J Am Geriatr Soc. 2019 Feb;67(2):284-291. doi: 10.1111/jgs.15654. Epub 2018 Nov 29.
2
Prevalence and determinants of Hyperpolypharmacy in adults with heart failure: an observational study from the National Health and Nutrition Examination Survey (NHANES).心力衰竭成人中超处方用药的流行情况及其决定因素:来自国家健康和营养调查(NHANES)的一项观察性研究。
BMC Cardiovasc Disord. 2019 Apr 1;19(1):76. doi: 10.1186/s12872-019-1058-7.
3
Association between polypharmacy and cognitive impairment in an elderly Japanese population residing in an urban community.在一个城市社区居住的日本老年人群体中,药物滥用与认知障碍之间的关联。
Geriatr Gerontol Int. 2017 Sep;17(9):1286-1293. doi: 10.1111/ggi.12862. Epub 2016 Sep 15.
4
Polypharmacy in Older Adults Hospitalized for Heart Failure.老年心力衰竭住院患者的多种药物治疗。
Circ Heart Fail. 2020 Nov;13(11):e006977. doi: 10.1161/CIRCHEARTFAILURE.120.006977. Epub 2020 Oct 13.
5
Reduced functionality in everyday activities of patients with self-reported heart failure hospitalization--population-based study results.自我报告有心力衰竭住院史患者日常活动功能减退——基于人群的研究结果
Int J Cardiol. 2014 Sep 20;176(2):423-9. doi: 10.1016/j.ijcard.2014.07.099. Epub 2014 Aug 4.
6
Heart Failure and Cognitive Impairment in the Atherosclerosis Risk in Communities (ARIC) Study.《动脉粥样硬化风险社区研究(ARIC)中心力衰竭与认知障碍》。
J Gen Intern Med. 2018 Oct;33(10):1721-1728. doi: 10.1007/s11606-018-4556-x. Epub 2018 Jul 20.
7
Self-Reported Medication Adherence Barriers Among Ambulatory Older Adults with Mild Cognitive Impairment.轻度认知障碍门诊老年患者自我报告的药物治疗依从性障碍
Pharmacotherapy. 2016 Feb;36(2):196-202. doi: 10.1002/phar.1702. Epub 2016 Feb 1.
8
Association Between Psychotropic Medication Polypharmacy and an Objective Measure of Balance Impairment Among Middle-Aged Adults: Results from the US National Health and Nutrition Examination Survey.中年成年人精神药物多药治疗与平衡障碍客观测量之间的关联:来自美国国家健康和营养检查调查的结果。
CNS Drugs. 2018 Sep;32(9):863-871. doi: 10.1007/s40263-018-0542-4.
9
Reduced cognitive function predicts functional decline in patients with heart failure over 12 months.认知功能减退预示着心力衰竭患者在12个月内的功能衰退。
Eur J Cardiovasc Nurs. 2014 Aug;13(4):304-10. doi: 10.1177/1474515113494026. Epub 2013 Jun 9.
10
Factors associated with ADL/IADL disability in community dwelling older adults in the Irish longitudinal study on ageing (TILDA).爱尔兰老年纵向研究(TILDA)中社区居住的老年人日常生活活动/工具性日常生活活动残疾相关因素。
Disabil Rehabil. 2017 Apr;39(8):809-816. doi: 10.3109/09638288.2016.1161848. Epub 2016 Apr 4.

引用本文的文献

1
How to handle polypharmacy in heart failure. A clinical consensus statement of the Heart Failure Association of the ESC.如何处理心力衰竭中的多重用药问题。欧洲心脏病学会心力衰竭协会的临床共识声明。
Eur J Heart Fail. 2025 May;27(5):747-759. doi: 10.1002/ejhf.3642. Epub 2025 Mar 17.
2
Prevalence of prescription medication use that can exacerbate heart failure among US adults with heart failure.美国成年心力衰竭患者中可加重心力衰竭的处方药使用情况。
Pharmacotherapy. 2025 Mar;45(3):155-160. doi: 10.1002/phar.4648. Epub 2025 Jan 20.
3
Folate in the United States Population and its Association with Congestive Heart Failure.美国人群中的叶酸及其与充血性心力衰竭的关联。
Rev Cardiovasc Med. 2024 Jan 29;25(2):39. doi: 10.31083/j.rcm2502039. eCollection 2024 Feb.
4
Definition of Polypharmacy in Heart Failure: A Scoping Review of the Literature.心力衰竭中多重用药的定义:文献综述
Cardiol Res. 2024 Apr;15(2):75-85. doi: 10.14740/cr1636. Epub 2024 Apr 15.
5
Association between Cognitive Impairment Severity and Polypharmacy in Older Patients with Atrial Fibrillation: A Retrospective Study Using Inpatient Data from a Specialised Geriatric Hospital.老年房颤患者认知障碍严重程度与多重用药之间的关联:一项使用专科医院住院患者数据的回顾性研究
Geriatrics (Basel). 2024 Jan 24;9(1):15. doi: 10.3390/geriatrics9010015.
6
Polypharmacy in Older People With Heart Failure: Roles of the Geriatrician and Pharmacist.老年心力衰竭患者的多重用药:老年医学专家和药剂师的作用
Card Fail Rev. 2022 Dec 19;8:e34. doi: 10.15420/cfr.2022.14. eCollection 2022 Jan.
7
Clinical Perspectives on Cardiac Rehabilitation After Heart Failure in Elderly Patients with Frailty: A Narrative Review.老年衰弱心力衰竭患者心脏康复的临床观点:一项叙述性综述
Ther Clin Risk Manag. 2022 Oct 27;18:1009-1028. doi: 10.2147/TCRM.S350748. eCollection 2022.
8
Polypharmacy among older individuals with heart failure: trends between 2000 and 2017 in the province of Quebec, Canada.心衰老年患者的多重用药情况:加拿大魁北克省 2000 年至 2017 年的趋势。
Ther Adv Cardiovasc Dis. 2022 Jan-Dec;16:17539447221113946. doi: 10.1177/17539447221113946.
9
Social Determinants of Health and 30-Day Readmissions Among Adults Hospitalized for Heart Failure in the REGARDS Study.《REGARDS 研究:导致心力衰竭成年人住院 30 天内再入院的社会决定因素》
Circ Heart Fail. 2022 Jan;15(1):e008409. doi: 10.1161/CIRCHEARTFAILURE.121.008409. Epub 2021 Dec 6.
10
Policy and Payment Challenges in the Postpandemic Treatment of Heart Failure: Value-Based Care and Telehealth.后疫情时代心力衰竭治疗的政策和支付挑战:基于价值的护理和远程医疗。
J Card Fail. 2022 May;28(5):835-844. doi: 10.1016/j.cardfail.2021.08.019. Epub 2021 Sep 11.

本文引用的文献

1
Heart Disease and Stroke Statistics-2018 Update: A Report From the American Heart Association.《2018年心脏病和中风统计数据更新:美国心脏协会报告》
Circulation. 2018 Mar 20;137(12):e67-e492. doi: 10.1161/CIR.0000000000000558. Epub 2018 Jan 31.
2
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.2017年美国心脏病学会/美国心脏协会/美国心力衰竭学会对2013年美国心脏病学会基金会/美国心脏协会心力衰竭管理指南的重点更新:美国心脏病学会/美国心脏协会临床实践指南工作组及美国心力衰竭学会的报告
J Am Coll Cardiol. 2017 Aug 8;70(6):776-803. doi: 10.1016/j.jacc.2017.04.025. Epub 2017 Apr 28.
3
Prioritizing Functional Capacity as a Principal End Point for Therapies Oriented to Older Adults With Cardiovascular Disease: A Scientific Statement for Healthcare Professionals From the American Heart Association.将功能能力作为面向老年心血管疾病患者的治疗的主要终点进行优先排序:美国心脏协会给医疗保健专业人员的科学声明。
Circulation. 2017 Apr 18;135(16):e894-e918. doi: 10.1161/CIR.0000000000000483. Epub 2017 Mar 23.
4
US Emergency Department Visits for Outpatient Adverse Drug Events, 2013-2014.2013 - 2014年美国急诊科门诊不良药物事件就诊情况
JAMA. 2016 Nov 22;316(20):2115-2125. doi: 10.1001/jama.2016.16201.
5
Electrophysiology and heart rhythm disorders in older adults.老年人的电生理学与心律失常
J Geriatr Cardiol. 2016 Aug;13(8):645-651. doi: 10.11909/j.issn.1671-5411.2016.08.001.
6
Geriatric Conditions in Patients Undergoing Defibrillator Implantation for Prevention of Sudden Cardiac Death: Prevalence and Impact on Mortality.接受除颤器植入以预防心源性猝死患者的老年疾病:患病率及其对死亡率的影响。
Circ Cardiovasc Qual Outcomes. 2016 Jan;9(1):23-30. doi: 10.1161/CIRCOUTCOMES.115.002053. Epub 2015 Dec 29.
7
Older Adults in Clinical Research and Drug Development: Closing the Geriatric Gap.临床研究与药物研发中的老年人:弥合老年差距
Circ Cardiovasc Qual Outcomes. 2015 Nov;8(6):631-3. doi: 10.1161/CIRCOUTCOMES.115.002158. Epub 2015 Oct 20.
8
Medication Initiation Burden Required to Comply With Heart Failure Guideline Recommendations and Hospital Quality Measures.遵循心力衰竭指南建议和医院质量指标所需的药物起始负担。
Circulation. 2015 Oct 6;132(14):1347-53. doi: 10.1161/CIRCULATIONAHA.115.014281. Epub 2015 Aug 27.
9
The number of discharge medications predicts thirty-day hospital readmission: a cohort study.出院带药数量可预测30天内再次入院:一项队列研究。
BMC Health Serv Res. 2015 Jul 23;15:282. doi: 10.1186/s12913-015-0950-9.
10
Reducing inappropriate polypharmacy: the process of deprescribing.减少不适当的多种药物治疗:减药过程。
JAMA Intern Med. 2015 May;175(5):827-34. doi: 10.1001/jamainternmed.2015.0324.

心力衰竭成年人的功能障碍与药物负担之间的关系。

Association Between Functional Impairment and Medication Burden in Adults with Heart Failure.

机构信息

Division of Cardiology, Department of Medicine, Weill Cornell Medicine, New York, New York.

Division of General Internal Medicine, Department of Medicine, Weill Cornell Medicine, New York, New York.

出版信息

J Am Geriatr Soc. 2019 Feb;67(2):284-291. doi: 10.1111/jgs.15654. Epub 2018 Nov 29.

DOI:10.1111/jgs.15654
PMID:30488944
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6790071/
Abstract

OBJECTIVES

To determine whether the number of medications taken by adults with heart failure (HF) and impairment in activities of daily living (ADL)-a subpopulation in whom the risks of a high medication burden may outweigh the benefits-differs from the number taken by those without impairment in ADLs.

DESIGN

Cross-sectional.

SETTING

National Health and Nutrition Examination Survey (NHANES; 2003-2014), a cross-sectional survey that produces national estimates of adults in the United States.

PARTICIPANTS

Adults aged 50 and older (mean 70) with self-reported HF (N= 947; representing 4.6 million adults with HF in the United States.

MEASURMENTS

We assessed ADL impairment and medication count based on self-report. ADL impairment was defined as having difficulty with or being unable to dress, feed oneself, or get in and out of bed. To determine the independent association between ADL impairment and medication count, we performed sequential Poisson multivariable regression analyses. All analyses were cross-sectional in nature and accounted for the complex survey design of NHANES.

RESULTS

Mean medication count was 7.2, and 74% of participants were taking 5 or more medications (polypharmacy). In a multivariable model, ADL impairment was not independently associated with medication count. These findings were similar for those with 3 or more hospitalizations in the prior year, declining health status, and cognitive impairment.

CONCLUSION

After adjusting for confounders including comorbidity, we found that adults with HF and ADL impairment take as many medications as those without ADL impairment. This suggests that providers may not sufficiently consider functional impairment when prescribing medications to adults with HF and thus may unnecessarily expose individuals to risk of adverse outcomes. J Am Geriatr Soc 67:284-291, 2019.

摘要

目的

确定患有心力衰竭(HF)和日常生活活动(ADL)受损的成年人(这一亚人群的高药物负担风险可能大于获益)服用的药物数量是否与无 ADL 受损的成年人不同。

设计

横断面研究。

地点

全国健康与营养调查(NHANES;2003-2014 年),这是一项横断面调查,可产生美国成年人的全国估计数。

参与者

年龄在 50 岁及以上(平均 70 岁),自述患有 HF(N=947;代表美国 460 万 HF 成年人)。

测量方法

我们根据自我报告评估 ADL 受损和药物计数。ADL 受损定义为穿衣、进食、上下床有困难或无法完成。为了确定 ADL 受损与药物计数之间的独立关联,我们进行了顺序泊松多变量回归分析。所有分析均为横断面性质,并考虑了 NHANES 的复杂调查设计。

结果

平均药物计数为 7.2,74%的参与者服用 5 种或更多药物(多种药物治疗)。在多变量模型中,ADL 受损与药物计数无独立相关性。这些发现对于过去一年有 3 次或更多次住院、健康状况下降和认知障碍的患者也是如此。

结论

在调整了包括合并症在内的混杂因素后,我们发现 HF 和 ADL 受损的成年人服用的药物与无 ADL 受损的成年人一样多。这表明,在为 HF 成年人开处方时,医生可能没有充分考虑到功能障碍,从而可能使个体不必要地面临不良后果的风险。J Am Geriatr Soc 67:284-291,2019。